falseQ30001865377--12-31 0001865377 2022-01-01 2022-09-30 0001865377 2021-12-31 0001865377 2022-09-30 0001865377 2022-09-30 2022-09-30 0001865377 2021-04-22 2021-09-30 0001865377 2021-07-01 2021-09-30 0001865377 2022-07-01 2022-09-30 0001865377 2021-04-22 2021-06-30 0001865377 2021-09-21 2021-09-21 0001865377 2021-09-24 2021-09-24 0001865377 2021-09-24 0001865377 2021-09-30 2021-09-30 0001865377 2022-04-01 2022-06-30 0001865377 2022-01-01 2022-03-31 0001865377 2021-04-22 0001865377 2021-06-30 0001865377 2021-08-26 2021-08-26 0001865377 2021-07-21 2021-07-21 0001865377 2022-08-16 2022-08-16 0001865377 2021-04-21 0001865377 2021-09-30 0001865377 2022-03-31 0001865377 2022-06-30 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember argu:PrivatePlacementWarrantMember 2022-09-30 0001865377 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember argu:PublicWarrantMember 2022-09-30 0001865377 argu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2022-09-30 0001865377 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2022-09-30 0001865377 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2022-09-30 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001865377 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember argu:PrivatePlacementWarrantMember 2022-09-30 0001865377 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2022-09-30 0001865377 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2022-09-30 0001865377 us-gaap:CommonClassBMember 2022-09-30 0001865377 us-gaap:CommonClassAMember 2022-09-30 0001865377 argu:PrivatePlacementWarrantsMember 2022-09-30 0001865377 argu:PublicWarrantMember 2022-09-30 0001865377 argu:PublicOfferingMember 2022-09-30 0001865377 us-gaap:CommonClassAMember argu:SharePriceEqualsOrExceedsEighteenUsdMember 2022-09-30 0001865377 argu:ClassANonredeemableCommonStockMember 2022-09-30 0001865377 us-gaap:HeldtomaturitySecuritiesMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001865377 us-gaap:USTreasurySecuritiesMember us-gaap:HeldtomaturitySecuritiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001865377 argu:SharePriceEqualsOrExceedsFourteenUsdMember argu:RestrictionsOnTransferOfFounderSharesEventMember us-gaap:CommonClassAMember 2022-09-30 0001865377 argu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember argu:PublicWarrantsMember us-gaap:CommonClassAMember 2022-09-30 0001865377 argu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember us-gaap:CommonClassAMember 2022-09-30 0001865377 argu:UnderwritingAgreementMember 2022-09-30 0001865377 us-gaap:AccountsPayableAndAccruedLiabilitiesMember argu:AdministrativeServicesFeeMember 2022-09-30 0001865377 argu:WorkingCapitalLoansMember 2022-09-30 0001865377 argu:SponsorMember 2022-09-30 0001865377 us-gaap:CashMember 2022-09-30 0001865377 us-gaap:USTreasurySecuritiesMember 2022-09-30 0001865377 us-gaap:USTreasuryBillSecuritiesMember us-gaap:HeldtomaturitySecuritiesMember 2022-09-30 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember argu:PrivatePlacementWarrantMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember argu:PublicWarrantMember 2021-12-31 0001865377 argu:MeasurementInputProbabilityOfCompletingBusinessCombinationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember argu:PrivatePlacementWarrantMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001865377 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001865377 us-gaap:CommonClassBMember 2021-12-31 0001865377 us-gaap:CommonClassAMember 2021-12-31 0001865377 argu:PublicOfferingMember 2021-12-31 0001865377 argu:ClassANonredeemableCommonStockMember 2021-12-31 0001865377 us-gaap:HeldtomaturitySecuritiesMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001865377 us-gaap:USTreasurySecuritiesMember us-gaap:HeldtomaturitySecuritiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001865377 us-gaap:AccountsPayableAndAccruedLiabilitiesMember argu:AdministrativeServicesFeeMember 2021-12-31 0001865377 us-gaap:CashMember 2021-12-31 0001865377 us-gaap:USTreasurySecuritiesMember 2021-12-31 0001865377 argu:WorkingCapitalLoansMember 2021-12-31 0001865377 us-gaap:HeldtomaturitySecuritiesMember us-gaap:USTreasuryBillSecuritiesMember 2021-12-31 0001865377 us-gaap:WarrantMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-07-01 2022-09-30 0001865377 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001865377 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001865377 argu:AdministrativeServicesFeeMember 2022-07-01 2022-09-30 0001865377 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001865377 us-gaap:NonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001865377 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001865377 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001865377 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001865377 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001865377 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001865377 us-gaap:USTreasurySecuritiesMember us-gaap:HeldtomaturitySecuritiesMember us-gaap:ChangeDuringPeriodFairValueDisclosureMember 2022-01-01 2022-09-30 0001865377 us-gaap:CapitalUnitsMember 2022-01-01 2022-09-30 0001865377 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001865377 argu:FounderSharesMember 2022-01-01 2022-09-30 0001865377 argu:BusinessCombinationMember 2022-01-01 2022-09-30 0001865377 us-gaap:IPOMember us-gaap:WarrantMember argu:PrivatePlacementWarrantMember 2022-01-01 2022-09-30 0001865377 us-gaap:IPOMember us-gaap:WarrantMember argu:PublicWarrantMember 2022-01-01 2022-09-30 0001865377 us-gaap:IPOMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001865377 argu:AdministrativeServicesFeeMember 2022-01-01 2022-09-30 0001865377 srt:MinimumMember 2022-01-01 2022-09-30 0001865377 us-gaap:NonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001865377 srt:MaximumMember 2022-01-01 2022-09-30 0001865377 us-gaap:CommonClassBMember 2021-04-22 2021-09-30 0001865377 us-gaap:CommonClassAMember 2021-04-22 2021-09-30 0001865377 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001865377 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001865377 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001865377 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-04-22 2021-06-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-04-22 2021-06-30 0001865377 us-gaap:RetainedEarningsMember 2021-04-22 2021-06-30 0001865377 argu:FounderSharesMember argu:SponsorMember 2021-09-21 2021-09-21 0001865377 argu:SponsorMember argu:PrivatePlacementWarrantMember 2021-09-21 2021-09-21 0001865377 us-gaap:CommonClassBMember 2021-09-21 2021-09-21 0001865377 argu:SponsorMember argu:FounderSharesMember 2021-09-21 0001865377 argu:SponsorMember argu:PrivatePlacementWarrantMember 2021-09-21 0001865377 argu:PrivatePlacementWarrantMember us-gaap:IPOMember 2021-09-24 2021-09-24 0001865377 us-gaap:IPOMember 2021-09-24 2021-09-24 0001865377 argu:PrivatePlacementWarrantMember 2021-09-24 2021-09-24 0001865377 argu:SponsorMember us-gaap:PrivatePlacementMember argu:PrivatePlacementWarrantsMember 2021-09-24 2021-09-24 0001865377 argu:SponsorMember us-gaap:PrivatePlacementMember 2021-09-24 2021-09-24 0001865377 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2021-09-24 2021-09-24 0001865377 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-09-24 2021-09-24 0001865377 argu:PublicWarrantsMember us-gaap:CommonClassAMember 2021-09-24 2021-09-24 0001865377 us-gaap:PrivatePlacementMember argu:PrivatePlacementWarrantsMember 2021-09-24 2021-09-24 0001865377 argu:SponsorMember argu:UnsecuredPromissoryNoteMember 2021-09-24 2021-09-24 0001865377 argu:AdministrativeServicesFeeMember 2021-09-24 2021-09-24 0001865377 argu:PrivatePlacementWarrantMember us-gaap:IPOMember 2021-09-24 0001865377 us-gaap:IPOMember 2021-09-24 0001865377 argu:SponsorMember argu:PrivatePlacementWarrantsMember 2021-09-24 0001865377 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-09-24 0001865377 us-gaap:CommonClassAMember 2021-09-24 0001865377 argu:PublicWarrantsMember us-gaap:CommonClassAMember 2021-09-24 0001865377 us-gaap:PrivatePlacementMember argu:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2021-09-24 0001865377 us-gaap:CommonClassAMember argu:PublicWarrantsMember 2022-06-30 2022-06-30 0001865377 argu:PublicWarrantMember 2022-09-30 2022-09-30 0001865377 argu:PublicOfferingMember 2022-09-30 2022-09-30 0001865377 us-gaap:CommonClassAMember 2022-09-30 2022-09-30 0001865377 argu:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2022-09-30 2022-09-30 0001865377 us-gaap:CommonClassAMember argu:RestrictionsOnTransferOfFounderSharesEventMember 2022-09-30 2022-09-30 0001865377 argu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember us-gaap:CommonClassAMember 2022-09-30 2022-09-30 0001865377 argu:UnderwritingAgreementMember us-gaap:IPOMember 2022-09-30 2022-09-30 0001865377 argu:PrivatePlacementWarrantsMember 2022-09-30 2022-09-30 0001865377 argu:SponsorMember argu:FounderSharesMember us-gaap:CommonClassBMember 2021-04-29 2021-04-29 0001865377 argu:FounderSharesMember argu:SponsorMember 2021-07-21 2021-07-21 0001865377 argu:FounderSharesMember argu:SponsorMember 2021-08-26 2021-08-26 0001865377 argu:SponsorMember argu:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-09-23 0001865377 argu:SponsorMember argu:UnsecuredPromissoryNoteMember 2021-04-22 0001865377 us-gaap:USTreasurySecuritiesMember us-gaap:HeldtomaturitySecuritiesMember us-gaap:ChangeDuringPeriodFairValueDisclosureMember 2021-01-01 2021-12-31 0001865377 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001865377 us-gaap:CommonClassAMember 2022-03-31 0001865377 us-gaap:CommonClassAMember 2022-06-30 0001865377 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:WarrantMember 2022-01-01 2022-06-30 0001865377 us-gaap:CommonClassAMember 2022-11-10 0001865377 us-gaap:CommonClassBMember 2022-11-10 0001865377 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001865377 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001865377 us-gaap:RetainedEarningsMember 2022-09-30 0001865377 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:WarrantMember 2022-09-30 0001865377 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-09-30 0001865377 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001865377 us-gaap:RetainedEarningsMember 2021-09-30 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001865377 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001865377 us-gaap:RetainedEarningsMember 2021-12-31 0001865377 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001865377 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001865377 us-gaap:RetainedEarningsMember 2022-03-31 0001865377 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001865377 us-gaap:RetainedEarningsMember 2022-06-30 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-04-21 0001865377 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-04-21 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-04-21 0001865377 us-gaap:RetainedEarningsMember 2021-04-21 0001865377 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001865377 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-06-30 0001865377 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001865377 us-gaap:RetainedEarningsMember 2021-06-30 0001865377 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:WarrantMember 2021-12-31 0001865377 us-gaap:WarrantMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-06-30 iso4217:USD xbrli:shares utr:Day utr:Year xbrli:pure utr:Month iso4217:USD xbrli:shares utr:Y

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission File Number

001-40827

Argus Capital Corp.

(Exact Name of Registrant as Specified in Its Charter)


Delaware		86-3426828
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

3 Columbus Circle, 24th Floor New York, New York		10019
(Address of Principal Executive Offices)		(Zip Code)

(212)

812-7702

(Registrant’s telephone number, including area code)

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant	ARGUU	The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share	ARGU	The Nasdaq Stock Market LLC
Redeemable warrants, each warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share	ARGUW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☒ No ☐

As of

November 10

, 2022, there were 30,475,000 shares of the registrant’s Class A common stock, par value $0.0001 per share, and 7,618,750 shares of the registrant’s Class B common stock, par value $0.0001 per share, outstanding.

Argus Capital Corp.

Quarterly Report on Form

10-Q

For the Quarter Ended September 30, 2022

Table of Contents


PART I. FINANCIAL INFORMATION

Item 1.	Interim Financial Statements

	Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021	1

	Condensed Statements of Operations for the three and nine months ended September 30, 2022 and the period from April 22, 2021 (inception) through September 30, 2021 (Unaudited)	2

	Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2022 and the three months ended September 30, 2021 and the period from April 22, 2021 (inception) through September 30, 2021 (Unaudited)	3

	Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and the period from April 22, 2021 (inception) through September 30, 2021 (Unaudited)	4

	Notes to Condensed Unaudited Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	24

Item 4.	Controls and Procedures	24

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	24

Item 1A.	Risk Factors	25

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	25

Item 3.	Defaults Upon Senior Securities	25

Item 4.	Mine Safety Disclosures	25

Item 5.	Other Information	25

Item 6.	Exhibits	25

PART III

	SIGNATURE	26

PART I. FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

ARGUS CAPITAL CORP.

CONDENSED BALANCE SHEETS


	September 30, 2022			December 31, 2021
	(Unaudited)
ASSETS:
Current assets:
Cash	$	81,518		$	1,230,768
Prepaid expenses		518,850			907,988

Total current assets		600,368			2,138,756
Cash and investments held in Trust Account		312,272,552			310,877,919

Total Assets	$	312,872,920		$	313,016,675

LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT:
Current liabilities:
Accounts payable and accrued expenses	$	1,016,289		$	1,059,424
Accrued franchise tax		150,000			97,310
Income taxes payable		88,863			—

Total current liabilities		1,255,152			1,156,734
Warrant liabilities		3,825,891			13,426,650
Deferred underwriting compensation		—			10,666,250

Total Liabilities		5,081,043			25,249,634

Commitments and Contingencies
Class A common stock subject to poss i ble redemption; 30,475,000 shares at $10.23 per share		311,933,689			310,845,000
Stockholders’ deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no nonredeemable shares issued and outstanding		—			—
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,618,750 shares issued and outstanding		762			762
Additional paid-in capital		—			—
Accumulated deficit		(4,142,574	)		(23,078,721	)

Total Stockholders’ Deficit		(4,141,812	)		(23,077,959	)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$	312,872,920		$	313,016,675

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARGUS CAPITAL CORP.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended September 30, 2022 (Unaudited)			Three Months Ended September 30, 2021 (Unaudited)			Nine Months Ended September 30, 2022 (Unaudited)			Period from April 22, 2021 (inception) through September 30, 2021
Operating Expenses:
General and administrative expenses	$	457,883		$	50,140		$	1,495,253		$	50,805
Franchise tax expense		50,000			88,767			150,000			88,767

Loss from operations		(507,883	)		(138,907	)		(1,645,253	)		(139,572	)
Other Income (Expense):
Interest earned on investments held in Trust Account		895,362			2,015			1,701,943			2,015
Gain on settlement of deferred underwriting commissions		—						10,666,250			—
Warrant issuance transaction costs		—			(1,277,720	)		—			(1,277,720	)
Change in fair value of warrant liabilities		994,567			(152,375	)		9,600,759			(152,375	)

Income (loss) before provision for income taxes		1,382,046			(1,566,987	)		20,323,699			(1,567,652	)
Provisions for Income Taxes		(164,003	)		—			(298,863	)		—

Net Income (Loss)	$	1,218,043		$	(1,566,987	)	$	20,024,836		$	(1,567,652	)

Weighted average number of shares of Class A common stock outstanding		30,475,000			1,987,500			30,475,000			1,128,704

Net income (loss) per share of common stock, Class A-basic and diluted	$	0.03		$	(0.16	)	$	0.53		$	(0.18	)

Weighted average number of shares of Class B common stock outstanding		7,618,750			7,618,750			7,618,750			7,618,750

Net income (loss) per share of common stock, Class B-basic and diluted	$	0.03		$	(0.16	)	$	0.53		$	(0.18	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARGUS CAPITAL CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the three and nine months ended September 30, 2022

(Unaudited)


	Common Stock								Additional Paid-in Capital		Accumulated Deficit			Total Stockholders’ Deficit
	Class A				Class B
	Shares		Amount		Shares		Amount
Balance at December 31, 2021		—	$	—		7,618,750	$	762	$	—	$	(23,078,721	)	$	(23,077,959	)
Net income		—		—		—		—		—		1,282,789			1,282,789

Balance at March 31, 2022 (unaudited)		—		—		7,618,750		762		—		(21,795,932	)		(21,795,170	)
Re-measurement for Class A common stock to redemption value		—		—		—		—		—		(307,330	)		(307,330	)
Net income		—		—		—		—		—		17,524,004			17,524,004

Balance at June 30, 2022 (unaudited)		—		—		7,618,750		762		—		(4,579,258	)		(4,578,496	)
Re-measurement for Class A common stock to redemption value		—		—		—		—		—		(781,359	)		(781,359	)
Net income		—		—		—		—		—		1,218,043			1,218,043

Balance at September 30, 2022 (unaudited)		—	$	—		7,618,750	$	762	$	—	$	(4,142,574	)	$	(4,141,812	)

For the three months ended September 30, 2021 and the period from April 22, 2021 (inception) through September 30, 2021

(Unaudited)


	Common Stock								Additional Paid-in Capital			Accumulated Deficit			Total Stockholders’ Equity (Deficit)
	Class A				Class B
	Shares		Amount		Shares		Amount
April 22, 2021 (inception)		—	$	—		—	$	—	$	—		$	—		$	—
Issuance of common stock to initial stockholder at $0.0022 per share (1)						7,618,750		762		24,238						25,000
Net loss		—		—		—		—		—			(665	)		(665	)

Balance at June 30, 2021 (unaudited)		—	$	—		7,618,750	$	762	$	24,238		$	(665	)	$	24,335
Issuance of common stock to initial stockholder at $0.0002 per share		—		—		—		—		1,540,266						1,540,266
Excess of cash received over fair value of Private Warrants		—		—		—		—		(1,564,504	)		(41,072,571	)		(42,637,075	)
Net loss		—		—		—		—		—			(1,566,987	)		(1,566,987	)

Balance at September 30, 2021 (unaudited)		—	$	—		7,618,750	$	762	$	—		$	(42,640,223	)	$	(42,639,461	)

(1)

Shares and the associated amounts have been adjusted to reflect the surrender of 2,875,000 and 1,437,000 shares of Class B common stock to the Company for no consideration on July 21, 2021 and August 26, 2021 and a 1:1.06 stock split of each outstanding share of Class B common stock on September 21, 2021 (see Note 4).

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARGUS CAPITAL CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended September 30, 2022			Period from April 22, 2021 (inception) through September 30, 2021
Cash flows from operating activities:
Net income (loss)	$	20,024,836		$	(1,567,652	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on investments held in Trust Account		(1,701,943	)		(2,015	)
Gain on settlement of deferred underwriting commissions		(10,666,250	)		—
Warrant issuance transaction cost		—			1,277,720
Change in fair value of warrant liabilities		(9,600,759	)		152,375
Changes in operating assets and liabilities:
Prepaid expenses		389,138			(1,024,907	)
Accounts payable and accrued expenses		(43,135	)		1,075,047
Accrued franchise tax		52,690			88,767
Income taxes payable		88,863			—

Net cash used in operating activities		(1,456,560	)		(665	)

Cash flows from investing activities:
Principal deposited in Trust Account		—			(310,845,000	)
Cash withdrawn from Trust account		307,310

Net cash provided by (used in) inves ting activities		307,310			(310,845,000	)

Cash flows from financing activities:
Proceeds from private placement of warrants		—			14,440,000
Proceeds from sale of units in initial public offering		—			304,750,000
Payment of underwriters’ discount		—			(6,095,000	)
Payment of offering costs		—			(532,883	)
Advances received from Promissory note		—			188,915
Repayment of advances received from Promissory note		—			(188,915	)
Net cash provided by financing activities		—			312,562,117
Increase (decrease) in cash during period		(1,149,250	)		1,716,452

Cash at beginning of period		1,230,768			—

Cash at end of period	$	81,518		$	1,716,452

Supplemental disclosure of cash flow information:
Cash paid during the period for income tax	$	210,000		$	—
Supplemental disclosure of non-cash investing and financing activities:
Deferred offering costs paid through Promissory Note	$	—		$	188,915
Offering costs paid by Sponsor in exchange for Class B common stock	$	—		$	25,000
Deferred offering costs included in accounts payable and accrued expenses	$	—		$	234,787
Deferred underwriting compensation	$	—		$	10,666,250

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARGUS CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

1.	Organization and Business Operations

Incorporation

Argus Capital Corp. (the “Company”), a blank check company, was incorporated in Delaware on April 22, 2021

As of September 30, 2022, the Company had not commenced any operations. All activity for the period

from

April 22, 2021 (inception) through September 30, 2022, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination (as defined below). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates

non-operating

income in the form of interest income earned on the Trust Account (as defined below).

Sponsor

The Company’s sponsor is Argus Sponsor LLC, a Delaware limited liability company (the “Sponsor”).

Business Purpose

The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses that it has not yet selected (“Business Combination”). The Company has neither engaged in any operations nor generated significant revenue to date.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its initial public offering of Units (as defined in Note 3 below) (the “Public Offering”), although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward completing a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully complete a Business Combination.

Financing

The registration statement for the Company’s Public Offering (as described in Note 4) was declared effective by the United States Securities and Exchange Commission (the “SEC”) on September 21, 2021. On September 21, 2021, the Sponsor agreed to purchase simultaneously with the closing of the Public Offering 9,626,667 warrants in a private placement at a price of $1.50 per warrant, generating gross proceeds of $14,440,000 (Note 4).

Upon the closing of the Public Offering and the private placement, $310,845,000 was placed in the Trust Account (discussed below).

Trust Account

The proceeds held in the trust account (the “Trust Account”) were invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

Table of Contents

Distribution from Trust Account

The Company’s amended and restated certificate of incorporation, dated September 21, 2021, provides that, other than the withdrawal of interest earned on the funds held in the Trust Account to pay taxes, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination within

18 months from the closing of the offering, or March 24, 2023; (ii) the redemption of any of the shares of Class A common stock included in the Units sold in the Public Offering (the “Public Shares”) to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete the Business Combination within the Combination Period (defined below) or with respect to any other material provisions relating to stockholders’ rights or

pre-initial

Business Combination activity or (iii) the redemption of 100% of Public Shares if the Company is unable to complete a Business Combination within the Combination Period.

Business Combination

The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares of Class A common stock, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, or (ii) provide stockholders with the opportunity to sell their shares of Class A common stock to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to commencement of the tender offer, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares of Class A common stock in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, the Company will only redeem the Public Shares so long as such redemption would not cause its Class A common stock to be considered “penny stock” (as such term is defined in Rule

3a51-1

under the Exchange Act). This may require the Company to not redeem the Public Shares, or not close its initial Business Combination, if it would result in the Company having less than $5,000,001 in net tangible assets unless another exemption from the definition of “penny stock” is available. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination.

If the Company holds a stockholder vote in connection with a Business Combination, a public stockholder will have the right to redeem its shares of Class A common stock for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the Trust Account but not previously released to the Company to pay taxes. As a result, such shares of Class A common stock will have been recorded at redemption amount and classified as temporary equity, in accordance with Financial Accounting Standards Board Accounting Standard Codification (“FASB ASC”) 480, “Distinguishing Liabilities from Equity.” The Company has 18 months from the closing of the Public Offering, or March 24, 2023, to complete its initial Business Combination (such period, as may be extended by a stockholder vote to amend the Company’s amended and restated certificate of incorporation, the “Combination Period”). If the Company does not complete a Business Combination within this period of time, it will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest, but less income taxes payable (less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire shares of Class A common stock in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.

Table of Contents

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.

Liquidity, Capital Resources and Going Concern

On September 24, 2021, the Company consummated a $304,750,000 Public Offering consisting of 30,475,000 units at a price of $10.00 per unit (“Unit”). Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value (the “Class A Common Stock”) and

one-half

of one redeemable warrant (each, a “Public Warrant”). Simultaneously, with the closing of the Public Offering, the Company consummated an approximately $14,440,000 private placement (“Private Placement”) of an aggregate of 9,626,667 warrants (“Private Placement Warrants”) at a price of $1.50 per warrant. Upon closing of the Public Offering and Private Placement on September 24, 2021, $310,845,000 in proceeds from the Public Offering and Private Placement was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. The remaining $8,345,000 held outside of the Trust Account was used to pay underwriting commissions of $6,095,000

related party note of $188,915, and accrued offering and formation costs.

As of September 30, 2022, the Company had an unrestricted cash balance of $81,518 as well as cash and investments held in the Trust Account of $312,272,552. The Company’s working capital needs will be satisfied through the funds, held outside of the Trust Account, from the Public Offering. Interest on funds held in the Trust Account may be used to pay taxes.

In September 2022, the Company paid $210,000 in estimated income tax.

Further, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The terms of such loans have not been determined and no written agreements exist with respect to such loans.

205-40,

“Presentation of Financial Statements—Going Concern,” management has determined that the liquidity condition and mandatory liquidation on March 24, 2023 and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 24, 2023. Management plans to consummate a Business Combination prior to March 24, 2023, however there can be no assurance that one will be completed.

Table of Contents

2.	Significant Accounting Policies

Basis of Presentation

These unaudited condensed financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The interim financial information provided is unaudited, but includes all adjustments which management considers necessary for the fair presentation of the results for the periods presented. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future periods and should be read in conjunction with the Company’s financial statements and notes thereto included in the Company’s Annual Report on

Form 10-K for

the period ended December 31, 2021, which was filed with the SEC on April 1, 2022.

Net Income (Loss) Per Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the

two-class

method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 15,237,500 Class A common stock in the aggregate. As of September 30, 2022

and 2021

, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per share of common stock is the same as basic net loss per share of common stock for the periods presented.

Table of Contents

	For the Three Months Ended September 30, 2022				For the Nine Months Ended September 30, 2022				For the Three Months Ended September 30, 2021						For the Period from April 22, 2021 to September 30, 2021
	Class A		Class B		Class A		Class B		Class A			Class B			Class A			Class B
Basic and diluted net income (loss) per share of common stock
Numerator:
Allocation of net income (loss)	$	974,434	$	243,609	$	16,019,869	$	4,004,967	$	(324,204	)	$	(1,242,783	)	$	(202,278	)	$	(1,365,374	)
Denominator:
Basic and diluted weighted average shares outstanding		30,475,000		7,618,750		30,475,000		7,618,750		1,987,500			7,618,750			1,128,704			7,618,750
Basic and diluted net income (loss) per share of common stock	$	0.03	$	0.03	$	0.53	$	0.53	$	(0.16	)		(0.16	)	$	(0.18	)	$	(0.18	)

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and is measured at redemption value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period.

Table of Contents

At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:



Gross proceeds	$	304,750,000
Less:
Proceeds allocated to Public Warrants		(20,265,875	)
Class A common stock issuance costs		(16,276,200	)
Plus:
Accretion of carrying value to redemption value		42,637,075

Class A common stock subject to possible redemption at December 31, 2021		310,845,000
Plus:
Accretion of carrying value to redemption value		—

Class A common stock subject to possible redemption at March 31, 2022		310,845,000
Plus:
Accretion of carrying value to redemption value		307,330

Class A common stock subject to possible redemption at June 30, 2022		311,152,330
Plus:
Accretion of carrying value to redemption value		781,359

Class A common stock subject to possible redemption at September 30, 2022	$	311,933,689

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued the amount of $16,276,200

were initially cha

ged to temporary equity and then it was accreted to common stock subject to redemption. Offering costs amounting to

1,277,720

were charged to the unaudited condensed statements of operations upon the completion of the Initial Public Offering (see Note

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account and the trust account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation Cover

age of $250,000. The Company has not experienced losses on this account.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in the unaudited condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.

Table of Contents

Income Taxes

The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was 12% and 0% for the three months ended September 30, 2022 and the three months ended September 30, 2021, respectively, and 1% and 0% for the nine months ended September 30, 2022 and the period from April 22, 2021 (inception) to September 30, 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and the three months ended September 30, 2021 and the period from April 22, 2021 (inception) to September 30, 2021, due to changes in fair value in warrant liabilities and the valuation allowance on the deferred tax assets.

There were no unrecognized tax benefits as of September 30, 2022 and December 31, 2021. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be

more-likely-than-not

to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature, except for the Warrant Liabilities (see Note 9).

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Table of Contents

Derivative Financial Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants and forward purchase agreements, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, will be

re-assessed

at the end of each reporting period. Derivative liabilities will be classified as

non-current

liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

The 24,864,167 warrants issued in connection with the Public Offering (including the 15,237,500 Public Warrants, as defined in Note 3, included in the Units and the 9,626,667 Private Placement Warrants will be recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities will be subject to

re-measurement

at each balance sheet date until exercised. The fair value of the Public Warrants and Private Warrants were initially measured at fair value using a Monte Carlo simulation model and Modified Black-Scholes option pricing model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value for determining the fair value of the Public Warrants. The fair value of the Private Placement Warrants is estimated at fair value using the Black-Scholes option pricing model.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt-Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. ASU

2020-06

is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU

2020-06

would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

3.	Public Offering

Public Units

On September 24, 2021, the Company sold 30,475,000 units, including the issuance of 3,975,000 units as a result of the underwriters’ exercise of their over-allotment option in full, at a price of $10.00 per unit (the “Units”) in the Public Offering. Each Unit consists of one share of Class A common stock of the Company, $0.0001 par value per share, and

one-half

of one warrant to purchase one share of Class A common stock (the “Public Warrants”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. Each Public Warrant will become exercisable 30 days after the completion of the Company’s Business Combination. The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, if the Company does not complete a Business Combination within the Combination Period, the Public Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of Public Warrants issued in connection with the 30,475,000 Units during the exercise period, there will be no net cash settlement of these Public Warrants and the Public Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement.

Table of Contents

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination (excluding any issuance of forward purchase securities), at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by its board of directors and, in the case of any such issuance to its initial stockholder or its affiliates, without taking into account any founder shares held by its initial stockholder or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial business combination on the date of the consummation of its initial business combination (net of redemptions), and (z) the volume weighted average trading price of its Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants for cash” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Company paid an upfront underwriting discount of 2.0% per Unit at the closing of the Public Offering, with an additional fee of 3.5% per Unit (the “Deferred Discount”) payable solely in the event the Company completes a Business Combination. In June 2022, the underwriters waived the Deferred Discount, resulting in a gain from settlement of deferred underwriting commissions of $10,666,250.

4.	Related Party Transactions

Founder Shares

On April 29, 2021, the Sponsor received 11,500,000 shares of Class B common stock (the “Founder Shares”) in exchange for a capital contribution of $25,000. On July 21, 2021 and August 26, 2021, the Sponsor returned to the Company for cancellation, at no cost, 2,875,000 and 1,437,500 founder shares, respectively, and on September 21, 2021, the Company effected a stock dividend of 0.06 shares for each Founder Share then outstanding, resulting in an aggregate of 7,618,750 founder shares outstanding and held by the Sponsor.

The Founder Shares are identical to the Public Shares except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below. In addition, up to 993,750 Founder Shares may be forfeited by the Sponsor depending on the exercise of the underwriters’ over-allotment option. On September 24, 2021, the underwriters’ exercised their over-allotment option in full and thus these shares are no longer subject to forfeiture.

The initial stockholder has agreed not to transfer, assign or sell any of their Founder Shares until the earlier of (A) two years after the completion of the Company’s initial Business Combination, or earlier if, subsequent to the Company’s initial Business Combination, the closing price of the Company’s shares of Class A common stock equals or exceeds $14.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 300 days after the Company’s initial Business Combination, and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property (the “Lock Up Period”).

Private Placement Warrants

The Sponsor purchased from the Company 9,626,667 warrants at a price of $1.50 per warrant (an aggregate purchase price of $14,440,000) in a private placement that occurred simultaneously with the completion of the Public Offering (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. From the sale of the Private Placement Warrants, $12,190,000 has been added to the proceeds from the Public Offering to be held in the Trust Account pending completion of the Company’s Business Combination. The Private Placement Warrants (including the shares of

Table of Contents

Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination, and they will be

non-redeemable

for cash so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers of the Private Placement Warrants or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants and have no net cash settlement provisions.

If the Company does not complete a Business Combination, then the proceeds will be part of the liquidating distribution to the public stockholders and the Private Placement Warrants will expire worthless.

Related Party Loans

On April 22, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Public Offering pursuant to a promissory note (the “Note”). The Note was

non-interest

bearing and payable on the earlier of December 31, 2021, or the completion of the Public Offering. On September 24, 2021, $188,915 then outstanding under the Note was repaid in

full, and borrowings under the Note are no longer available.

Administrative Services Agreement

The Company entered into an administrative services agreement in which the Company will pay an affiliate of its Chief Executive Officer for office space and secretarial and administrative services provided to members of the Company’s management team in an amount not to exceed $20,000 per month. The administrative services fee commenced on September 24, 2021. For the three and nine months ended September 30, 2022, the Company incurred $60,000 and $180,000, respectively, in administrative services expenses under the arrangement. As of September 30, 2022 and December 31, 2021, $240,000 and $60,000, respectively, are included in accounts payable and accrued expenses in the accompanying condensed balance sheets.

Working Capital Loans

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. There have been no borrowings under this arrangement to date. As of September 30, 2022 and December 31, 2021, there were no working capital loans outstanding.

5.	Commitments and Contingencies

Risks and Uncertainties

Management is continuing to evaluate the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impacts are not readily determinable as of the dates of the unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Registration Rights

The Sponsor will be entitled to registration rights pursuant to a registration rights agreement signed on September 21, 2021. The Sponsor will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities and any other securities of the Company acquired by the Sponsor prior to the consummation of the Company’s initial Business Combination for sale under the Securities Act. In addition, the Sponsor will have “piggy-back” registration rights to include its securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Table of Contents

6.	Trust Account

A total of $310,845,000, which includes $298,655,000 of the net proceeds from the Public Offering and $12,190,000 from the sale of the Private Placement Warrants, has been placed in the Trust Account.

As of September 30, 2022, investment securities in the Company’s Trust Account consisted of $311,050,060 in United States Treasury Bills and $1,222,492 held as cash. As of December 31, 2021, investment securities in the Company’s Trust Account consisted of $310,877,120 in United States Treasury Bills and $799 held as cash.

The Company classifies its Treasury Instruments and equivalent securities as

held-to-maturity

in accordance with FASB ASC 320 “Investments—Debt and Equity Securities”.

Held-to-maturity

securities are those securities which the Company has the ability and intent to hold until maturity.

Held-to-maturity

treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. The following table presents fair value information as of September 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In addition, the table presents the carrying value (held to maturity), excluding accrued interest income and gross unrealized holding loss.

Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows:


	Carrying Value		Gross Unrealized Holding (Loss)			Quoted Prices in Active Markets (Level 1)
U.S. Government Treasury Securities as of September 30, 2022 (1)	$	311,050,060	$	178,066		$	311,228,126
U.S. Government Treasury Securities as of December 31, 2021 (2)	$	310,877,120	$	(9,429	)	$	310,867,691

(1)	Maturity date December 15, 2022.

(2)	Maturity date March 24, 2022.

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period.

There were no transfers between levels for the three and nine months ended September 30, 2022.

There were no

transfers between levels for the period from April 22, 2021 (inception) to September 30, 2021.

Level 1 instruments consist of investments in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

7.	Stockholders’ Equity (Deficit)

Class

A Common Stock -

The Company is authorized to issue 380,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were no shares of Class A common stock issued and outstanding, except for 30,475,000 shares subject to possible redemption.

Table of Contents

Class

B Common Stock -

The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s Class B common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 7,618,750 shares of Class B common stock issued and outstanding.

Preferred stock -

The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2022 and December 31, 2021, no shares of preferred stock were issued and outstanding.

8.	Warrant Liabilities

As of September 30, 2022 and December 31, 2021, the Company has 24,864,167 warrants issued in connection with the Public Offering, consisting of 15,237,500 Public Warrants and 9,626,667 Private Placement Warrants, which are accounted for in accordance with the guidance contained in ASC

815-40.

Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company classified each warrant as a liability at its fair value, with the change in the fair value recognized in the Company’s statement of operations.

The Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants

- Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

Table of Contents

•

upon a minimum of 30 days’ prior written notice of redemption, or the

30-day

redemption period to each warrant holder; and

•

if, and only if, the last reported sale price of the Common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a

30-trading

day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Public Offering except that the holders of the Private Placement Warrants have agreed that the Private Placement Warrants and the Common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be

non-redeemable,

except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

9.	Fair Value Measurements

The following table presents information about the Company’s financial liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021, by level within the fair value hierarchy:


	Level		December 31, 2021		September 30, 2022
Warrant liabilities-Public		1	$	8,228,250	$	2,285,625
Warrant liabilities-Private		3	$	5,198,400	$	1,540,266

Table of Contents

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the period from January 1, 2022 to September 30, 2022.

The fair value of the Public Warrants and Private Warrants were initially measured at fair value using a Monte Carlo simulation model and Modified Black-Scholes option pricing model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value for determining the fair value of the Public Warrants. For the three and nine months ended September 30, 2022, the Company recognized a

non-operating

gain resulting from a decrease in the fair value of liabilities of $994,567 and $9,600,759,

respectively, presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed statements of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in both the Modified Black-Scholes Option pricing model and the Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants as adjusted for the estimated probability of completing an initial business combination. The risk-free interest rate is based on the U.S. Treasury

zero-coupon

yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	As of December 31, 2021			As of September 30, 2022
Exercise price	$	11.50		$	11.50
Stock price	$	9.90		$	10.04
Volatility for private warrants		8.4	%		17.4	% (2)
Term		6.06			5.48
Risk-free rate		1.36	%		4.13	%
Dividend yield		0	%		0	%
Probability of completing Business Combination		100	% (1)		8	% ( 3 )

(1)	Estimate based on completed SPAC market data published by third party as of December 31, 2021.

(2)	Estimate based on public trading of rights for SPACs and their implied business combination probabilities as of September 30, 2022.

(3)	Estimate based on list of SPACs with completion deadlines within three months of the Company’s completion deadline that have not announced a pending initial business combination (Spacinsider.com).

Table of Contents

The change in the fair value of the Level 3 warrant liabilities for the three and nine months ended September 30, 2022 is summarized as follows:



Level 3 Derivative warrant liabilities at December 31, 2021	$	5,198,400
Change in fair value of derivative warrant liabilities		(3,273,067	)

Level 3 Derivative warrant liabilities at June 30, 2022		1,925,333
Change in fair value of derivative warrant liabilities		(385,067	)

Level 3 Derivative warrant liabilities at September 30, 2022	$	1,540,267

10.	Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Quarterly Report on Form 10-Q includes forward-looking statements. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Factors that might cause or contribute to such forward-looking statements include, but are not limited to, those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s offering filed with the SEC. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.

Overview

We are a blank check company incorporated on April 22, 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). We consummated our Public Offering (as defined below) on September 24, 2021 and are currently in the process of locating suitable targets for our initial Business Combination. We intend to use the cash proceeds from our Public Offering and the Private Placement described below as well as additional issuances, if any, of our capital stock, debt or a combination of cash, stock and debt to complete the Business Combination.

We expect to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful.

Liquidity and Capital Resources

On September 24, 2021, the Company consummated its $304,750,000 Public Offering consisting of 30,475,000 units at a price of $10.00 per unit (“Unit”). Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value (the “Class A Common Stock”) and one-half of one redeemable warrant (each, a “Public Warrant”). Simultaneously, with the closing of the Public Offering, the Company consummated a $14,440,000 private placement (“Private Placement”) of an aggregate of 9,626,667 warrants (“Private Placement Warrants”) at a price of $1.50 per warrant. Upon closing of the Public Offering and Private Placement on September 24, 2021, $310,845,000 in proceeds from the Public Offering and Private Placement was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee (the “Trust Account”). The Company also used funds held outside of the Trust Account to pay underwriting commissions of $6,095,000 and deferred offering and formation costs.

For the nine months ended September 30, 2022, cash used in operating activities was $1,456,560. Net income of $20,024,836 was attributable to the change in fair value of warrant liabilities of $9,600,759, gain on settlement of deferred underwriting commissions of $10,666,250, interest earned on marketable securities held in the Trust Account of $1,701,943 and changes in operating assets and liabilities which provided $487,556 in cash from operating activities.

As of September 30, 2022, the Company had cash and marketable securities held in the Trust Account of $312,272,552. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete a Business Combination. The Company may withdraw interest to pay franchise and income taxes. During the three months ended September 30, 2022, the Company withdrew $307,310 from the Trust Account for franchise and income taxes. To the extent that the Company’s capital stock or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue its growth strategies.

As of September 30, 2022, the Company had an unrestricted cash balance of $81,518 held outside the Trust Account. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

Further, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company will repay such additional loaned amounts, without interest, upon consummation of the Business Combination. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such additional loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such additional loans (if any) are convertible into warrants, at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period. Except for the foregoing, the terms of such additional loans (if any) have not been determined and no written agreements exist with respect to such loans.

If the Company is unable to complete a business combination by March 24, 2023, then the Company will cease all operations except for the purpose of liquidating. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,” management has determined that the liquidity condition and mandatory liquidation on March 24, 2023 and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 24, 2023. Management plans to consummate a Business Combination prior to March 24, 2023, however there can be no assurance that one will be completed.

Results of Operations and Known Trends or Future Events

We have neither engaged in any significant business operations nor generated any revenues to date. All activities to date relate to the Company’s formation and the Public Offering (the “Public Offering”). We expect to generate non-operating income in the form of interest income on cash, cash equivalents, and marketable securities that will be held in the Trust Account (as defined below). We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses as we locate a suitable Business Combination.

For the three months ended September 30, 2022, we had a net income of $1,218,043, which consists of interest earned on marketable securities held in the Trust Account of $895,362, and the change in fair value of warrant liabilities of $994,567, offset by operating costs of $507,883 and provision for income taxes of $164,003. For the period from April 22, 2021 to September 30, 2021, we had a net loss of $1,566,987, which consists of interest earned on marketable securities held in the Trust Account of $2,015 offset by loss on the change in fair value of warrant liabilities of $152,375, warrant issuance transactions costs of $1,277,720 and operating costs of $138,907. For the nine months ended September 30, 2022, we had a net income of $20,024,836, which consists of interest earned on marketable securities held in the Trust Account of $1,701,943, the change in fair value of warrant liabilities of $9,600,759, and gain on settlement of deferred underwriting commissions of $10,666,250, offset by operating costs of $1,645,253 and provision for income taxes of $298,863. Through September 30, 2022 our efforts have been limited to organizational activities, activities relating to the Public Offering, activities relating to identifying and evaluating prospective acquisition candidates and activities relating to general corporate matters. We have not generated any revenue, other than interest income earned on the proceeds held in the Trust Account. As of September 30, 2022, $312,272,552 was held in the Trust Account (including $10,666,250 of deferred underwriting discounts and commissions and approximately $8.9 million from the Private Placement) and we had cash outside of the Trust Account of $81,518 and $1,016,289 in accounts payable and accrued expenses.

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $20,000 for office space, utilities and secretarial, and administrative support services to the Company. We began incurring these fees on September 25, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination or the Company’s liquidation.

The underwriters were entitled to a deferred fee of $0.35 per Unit, or $10,666,250 in the aggregate, payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In June 2022, the underwriters waived their deferred fee, resulting in a gain from settlement of deferred underwriting commissions of $10,666,250.

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Policies

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed financial statements and accompanying notes. Actual results could differ from those estimates. The Company has identified the following as its critical accounting policies:

Warrant Liability

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815. We account for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using the Black-Scholes option and the Monte Carlo simulation model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price will be used as the fair value as of each relevant date.

Investments Held in Trust Account

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and is measured at redemption value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheets.

Net Income (Loss) Per Share

Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Off-Balance Sheet Arrangement

We did not have any off-balance sheet arrangements as of September 30, 2022 as defined in Item 303(a)(4)(ii) of Regulation S-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

We have not engaged in any hedging activities since our inception. We do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (who serves as our Principal Executive Officer) and Chief Financial Officer (who serves as our Principal Financial and Accounting Officer), as appropriate, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, as of the end of the period covered by this report.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K/A filed with the SEC on April 1, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

A new 1% U.S. federal excise tax could be imposed on us in connection with redemptions by us of our shares in connection with a Business Combination.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury Department”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination or otherwise may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury Department. In addition, because the excise tax would be payable by us, and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete our initial Business Combination and in our ability to complete our initial Business Combination.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Exhibit Index


Exhibit No.		Description

31.1*		Certification of Chief Executive Officer pursuant to Rules 13a-14 and 15d-14 promulgated under the Securities Exchange Act of 1934

31.2*		Certification of Chief Financial Officer pursuant to Rules 13a-14 and 15d-14 promulgated under the Securities Exchange Act of 1934

32.1**		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*		Inline XBRL Instance Document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith

**	Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	ARGUS CAPITAL CORP.

Date: November 10, 2022	By:	/s/ Joseph R. Ianniello
		Name: Joseph R. Ianniello
		Title: Chief Executive Officer
		(Principal Executive Officer)

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

Argus Capital Corp. 10-Q